CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels

Thrombosis and Haemostasis

Volumn 92, Issue 2, 2004, Pages 419-424

  Schlitt, Axel ^a   Heine, Gunnar H ^b   Blankenberg, Stefan ^a   Espinola Klein, Christine ^a   Dopheide, Joern F ^a   Bickel, Christoph ^a   Lackner, Karl J ^a   Iz, Mete ^a   Meyer, Juergen ^a   Darius, Harald ^a   Rupprecht, Hans J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

CD14+CD16+ monocytes; Coronary artery disease; TNF alpha

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 4444245592     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th04-02-0095     Document Type: Article

References (27)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Stary HC, et al. A definition of advanced types of atheroslerotic lesions and a histological classification of atherosclerosis. Circulation 1995; 92: 1355-74
3. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterisation of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74: 2527-34
4. Fingerle G, et al. The novel subset of CD14+ CD16+ monocytes is expanded in sepsis patients. Blood 1993; 82: 3170-6.
5. Nockher WA, Scherberich JE. Expanded CD14+CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Inf Immun 1998; 66: 2782-90.
6. Sester U, Sester M, Heine G, et al. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 2001; 16: 1402-8.
7. Belge KU, et al. The proinflammatory CD14+ CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168: 3536-42.
8. Frankenberger M, et al. Differential cytokine expression in human blood monocyte subpopulations: A polymerase chain reaction analysis. Blood 1996; 87: 373-7.
9. Lindmark E, Diderholm E, Wallentin L, et al. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001; 286: 2107-13.
10. Porsch-Oezcueruemez M, Kunz D, Kloer HU, et al. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J Am Coll Cardiol 1999; 34: 1995-2001
11. Koukonnen H, Pentilla K, Kemppainen A, et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001; 33: 37-47.
12. Girndt M. Humoral immune responses in uremia and the role of IL-10. Blood Purif 2002; 20: 485-8.
13. Skoog T, Dichtl W, Boquist S, et al. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 2002; 23: 376-83.
14. Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-55.
15. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
16. Ziegler-Heitbrock HW. Definition of human blood monocytes. J Leukoc Biol 2000; 67: 603-6.
17. Muller WA. New mechanisms and pathways for monocyte recruitment. J Exp Med 2001; 194:F47-51.
18. Ancuta P, et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 2003; 197: 1701-7.
19. Umehara H, Bloom E, Okazaki T, et al. Fractalkine and vascular injury. Trends Immunol 2001; 22: 602-7.
20. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-4.
21. Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998; 188: 1413-9.
22. Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003; 111: 333-40.
23. Combadiere C, Potteaux S, Gao JL, et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 2003; 107: 1009-16.
24. McDermott DH, Fong AM, Yang Q, et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 2003; 111: 1241-50.
25. Rothe G, Gabriel H, Kovacs E, et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16: 1437-47.
26. Rothe G, et al. A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis 1999; 144: 251-61.
27. Patino R, et al. Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression. Am J Cardiol 2000; 85: 1288-91.